Intertek Pharmaceutical News

|

|

|

|

|

|

|

|

Intertek OCA Home > Intertek Pharmaceutical Services > News

Intertek Pharmaceutical Services News

News and Developments from Intertek Pharmaceutical Services

New Heparin Ph. Eur. - NMR and CE Analysis (July 2008)
Intertek NWTC Celebrates its 5th Birthday (July 2008)
Services for Contamination by Mesilate Esters (July 2008)
Possible Contamination of Medicinal Products by Mesilate Esters (June 2008)
New Stability Study Facility Launched for Routine and Complex Studies (June 2008)
Services for Antibody Therapeutics (May 2008)
Intertek BioClin Moves into New Facility (May 2008)
GMP XRD Service Launch (May 2008)
Allergen Screening Services (May 2008)
New Services for Interaction Studies of Skin with Pharmaceutical & Personal Care Products (May 2008)
New Stability Study Capability Commissioned (April 2008)
Biopharmaceutical Aggregation Studies (March 2008)
Heparin Impurity Screening (March 2008)
Intertek Acquires BioClin Laboratory in Ireland (February 2008)
Intertek ASG in Bio-pharmaceutical Consortium Project (November 2007)
Intertek Acquires QTI Laboratory (June 2007)
Trade Delegation Visits Intertek ASG (June 2007)
Intertek Acquires Alta Analytical Laboratory (December 2006)

Intertek Pharmaceutical Events and Seminars

Contact for more information
Americas Email Enquiries
Europe Email Enquiries
Asia Email Enquires

Prefer to Call?
Americas: 1 908 534 4445, x669
Europe: +44 (0) 161 721 5247


Intertek Group, Plc \| Intertek OCA Disclaimer \| Terms and Conditions	Home \| Locations \| Services \| News \| Contact Us \| Site Map